中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2013年
3期
246-251
,共6页
李庆%刘红星%孙慧%王倩%张之芬%武焕玲%李元堂%陈永金%田文君
李慶%劉紅星%孫慧%王倩%張之芬%武煥玲%李元堂%陳永金%田文君
리경%류홍성%손혜%왕천%장지분%무환령%리원당%진영금%전문군
白血病,髓系,慢性,BCR-ABL阳性%融合蛋白质类,bcr-abl%蛋白酪氨酸激酶类%突变%聚合酶链反应
白血病,髓繫,慢性,BCR-ABL暘性%融閤蛋白質類,bcr-abl%蛋白酪氨痠激酶類%突變%聚閤酶鏈反應
백혈병,수계,만성,BCR-ABL양성%융합단백질류,bcr-abl%단백락안산격매류%돌변%취합매련반응
Leukemia,myelogenous,chronic,BCR-ABL positive%Fusion proteins,bcr-abl%Protein-tyrosine kinases%Mutation%Polymerase chain reaction
目的 探讨用低变性温度共扩增PCR(COLD-PCR)方法提高BCR-ABL1融合基因激酶区耐药突变检测灵敏度的可行性.方法 本研究为实验诊断研究.设计常规巢式PCR(CN-PCR)和COLD-PCR方案扩增BCR-ABL1激酶区全长,扩增产物纯化后用Sanger测序法检测激酶区突变(KDM).采集32例经伊马替尼(IM)治疗并出现耐药的慢性粒细胞性白血病(CML)患者和20例初诊CML患者外周血或骨髓标本,用上述2种方案检测标本中的KDM.用PCR扩增和基因克隆方法鉴定患者标本中KDM所占比例.制备含不同KDM比例的标准品,对比分析2种方法的检测灵敏度.结果 32例IM耐药患者中,共检出15种KDM.其中用CN-PCR方法检出23例(71.9%) KDM阳性,用COLD-PCR检出28例(87.5%) KDM阳性.在20例初诊CML患者中,用CN-PCR未检出KDM,用COLD-PCR方法检出1例有p.E459K突变,突变型基因比例为3.5%.对于16种不同类型的KDM,COLD-PCR方法可提高检测灵敏度4~12倍.结论 用COLD-PCR方法可有效提高BCR-ABL1激酶区耐药突变的检测灵敏度,有助于早期发现耐药突变.
目的 探討用低變性溫度共擴增PCR(COLD-PCR)方法提高BCR-ABL1融閤基因激酶區耐藥突變檢測靈敏度的可行性.方法 本研究為實驗診斷研究.設計常規巢式PCR(CN-PCR)和COLD-PCR方案擴增BCR-ABL1激酶區全長,擴增產物純化後用Sanger測序法檢測激酶區突變(KDM).採集32例經伊馬替尼(IM)治療併齣現耐藥的慢性粒細胞性白血病(CML)患者和20例初診CML患者外週血或骨髓標本,用上述2種方案檢測標本中的KDM.用PCR擴增和基因剋隆方法鑒定患者標本中KDM所佔比例.製備含不同KDM比例的標準品,對比分析2種方法的檢測靈敏度.結果 32例IM耐藥患者中,共檢齣15種KDM.其中用CN-PCR方法檢齣23例(71.9%) KDM暘性,用COLD-PCR檢齣28例(87.5%) KDM暘性.在20例初診CML患者中,用CN-PCR未檢齣KDM,用COLD-PCR方法檢齣1例有p.E459K突變,突變型基因比例為3.5%.對于16種不同類型的KDM,COLD-PCR方法可提高檢測靈敏度4~12倍.結論 用COLD-PCR方法可有效提高BCR-ABL1激酶區耐藥突變的檢測靈敏度,有助于早期髮現耐藥突變.
목적 탐토용저변성온도공확증PCR(COLD-PCR)방법제고BCR-ABL1융합기인격매구내약돌변검측령민도적가행성.방법 본연구위실험진단연구.설계상규소식PCR(CN-PCR)화COLD-PCR방안확증BCR-ABL1격매구전장,확증산물순화후용Sanger측서법검측격매구돌변(KDM).채집32례경이마체니(IM)치료병출현내약적만성립세포성백혈병(CML)환자화20례초진CML환자외주혈혹골수표본,용상술2충방안검측표본중적KDM.용PCR확증화기인극륭방법감정환자표본중KDM소점비례.제비함불동KDM비례적표준품,대비분석2충방법적검측령민도.결과 32례IM내약환자중,공검출15충KDM.기중용CN-PCR방법검출23례(71.9%) KDM양성,용COLD-PCR검출28례(87.5%) KDM양성.재20례초진CML환자중,용CN-PCR미검출KDM,용COLD-PCR방법검출1례유p.E459K돌변,돌변형기인비례위3.5%.대우16충불동류형적KDM,COLD-PCR방법가제고검측령민도4~12배.결론 용COLD-PCR방법가유효제고BCR-ABL1격매구내약돌변적검측령민도,유조우조기발현내약돌변.
Objective To evaluate the feasibility of the co-amplification using a low denaturation temperature PCR (COLD-PCR) method in improving the detection of BCR-ABL1 fusion gene kinase domain drug-resistant mutation.Methods Conventional nested PCR (CN-PCR) and COLD-PCR protocol were designed to amplify full-length of BCR-ABL1 kinase domain.PCR products were purified and then Sanger sequenced to detect BCR-ABL1 kinase domain mutation (KDM).20 newly diagnosed CML patients and 32 Imatinib (IM) resistant patients were chosen and peripheral blood or bone marrow samples were collected.PCR products of the clinical specimens were purified and then cloned to evaluate the proportion of the KDM allele.Standard samples with different proportion of KDMs were prepared using T-A vectors with KDM and wild type BCR-ABL1 kinase domain sequence,and then CN-PCR,COLD-PCR and Sanger sequencing were performed to compare the detection sensitivity.Results In the 32 IM-resistant patients,23 were identified KDM-positive using CN-PCR and 28 KDM-positive using COLD-PCR.In the 20 newly diagnosed CML patients,none was identified KDM-positive using CN-PCR and 1 was identified carrying a lower proportion of KDM using COLD-PCR.For 16 different types of KDMs,COLD-PCR method could improve the detection sensitivity 4-12 times.Conclusion Detection sensitivity of BCR-ABL1 drug-resistant kinase domain mutation can be effectively improved by using COLD-PCR method and may contribute to early detection of resistance KDMs.